Company intelligence / Profile preview

B Hafkin and Associates, Inc.

Austin, Texas, United Stateslinkedin.com ↗
Ownership
Private
Development stage
Phase 2
01

Overview

B Hafkin and Associates, Inc. appears to be an active healthcare consultancy led by Dr. Barry Hafkin, an infectious disease specialist based in Austin, Texas. The company provides expert consultation services but does not develop therapeutics or maintain a clinical pipeline[1][3].

Industry
Consulting
02

Drug pipeline

1 asset

afabicin

Phase 2
Indications
Acute bacterial skin and skin structure infections, Staphylococcus aureus infections

Beyond the preview

Go deeper on B Hafkin and Associates, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on B Hafkin and Associates, Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call